US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

39.61

0.0000

Volume:78

Turnover:3.08K

Market Cap:2.97M

PE:- -

High:39.61

Open:39.61

Low:39.61

Close:39.61

52wk High:45.88

52wk Low:25.71

Shares:75.00K

Float Shares:75.00K

Volume Ratio:0.02

T/O Rate:0.10%

Dividend:0.62

Dividend Rate:1.57%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s Investors

Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China

Biofrontera announces FDA approval of Ameluz supplemental new drug application

FDA Approves Shorter Monitoring Time for Amgen’s Imdelltra First Two Doses

Amgen - Imdelltra Monitoring Reduced to 6-8 Hours for First Two Infusions

THOMSON REUTERS

Amgen - Imdelltra Monitoring Remains 6-8 Hours for Third Dose, 3-4 Hours for Cycles 3-4

THOMSON REUTERS

FDA Approves Reduced Monitoring Time for First Two Doses of Imdelltra®

THOMSON REUTERS

Amgen - Patients to Receive Follow-up Assessment After First Two Imdelltra Doses

THOMSON REUTERS

Scholar Rock Wins FDA Approval for SMA Therapy

Scholar Rock price target raised to $84 from $76 at BMO Capital

Sino Biopharmaceutical Stock Advances 4.3% in Hong Kong, Outperforms Competitors

Vertex Minerals Revises Timeline for Proposed Securities Issue

Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Palo Alto, Eaton, Amgen, SpaceX, LMT Trending With Analysts

Scholar Rock announces FDA approval of isembyld

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/TBXU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":39.6136,"timestamp":1789745145682,"preClose":39.6136,"halted":0,"volume":78,"delay":0,"changeRate":0,"floatShares":75001,"shares":75001,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"09-18 12:02:23 EDT","open":39.6136,"high":39.6136,"low":39.6136,"amount":3076.341294,"amplitude":0,"askPrice":39.25,"askSize":400,"bidPrice":39.14,"bidSize":400,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789761600000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":39.6136,"sharesOutstanding":100001,"nav":38.569,"aum":2892712,"dividendRate":0.015697,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":38.5642,"preClose":39.6136,"latestTime":"16:10 EDT","volume":6,"amount":237.6816,"timestamp":1789675804466,"change":-1.0494,"changeRate":-0.026491,"amplitude":0},"volumeRatio":0.02242},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":75001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.02242,"shares":75001,"dividePrice":0.6218,"high":39.6136,"amplitude":0,"preClose":39.6136,"low":39.6136,"week52Low":25.71,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":39.6136,"eps":0,"divideRate":0.015697,"volume":78,"delay":0,"ttmEps":0,"open":39.6136,"prevYearClose":31.065,"prevWeekClose":38.3601,"prevMonthClose":42.9245,"prevQuarterClose":32.1223,"fiveDayClose":38.3601,"twentyDayClose":43.3255,"sixtyDayClose":30.1137},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667109456","title":"Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2667109456","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667109456?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:33","pubTimestamp":1789461180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slipped 1.0% to 5.42 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.0% to 24667.24.Sino Biopharmaceutical Ltd. closed 38% below its 52-week high of HK$8.81, which the company achieved Sept. 16.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 1.9% and Amgen Inc. remained unchanged.Trading volume totaled 59.4 million shares, compared to the 50-day average of 95.3 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","LU0058720904.USD","BK4534","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","TBXU","BK4566","BIB","IE00BZ08YS42.EUR","SG9999001440.SGD","PJP","IE00BJT1NW94.SGD","LU1983299246.USD","LU2112291526.USD","LU0868494617.USD","BK1191","BK1589","AMGN","LU2242652126.USD","BK4588","HK0000165453.HKD","IE00BZ08YR35.GBP","LU1571399168.USD","IE0009355771.USD","LU0122379950.USD","LU0289739699.SGD","BBH","LU0889565916.HKD","BK4581","BK1521","BK4599","LU2089984988.USD","BK4533","IE00BZ08YT58.USD","LU1061106388.HKD","LU0109394709.USD","LU1057294990.SGD","01177","IE00B2B36J28.USD","PBE","IBBQ","LU2468319806.SGD","LU2242646821.SGD","BK4139","BK1515","IE0002141913.USD","BK4585","IE00BFTCPJ56.SGD","LU0320765992.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695453","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695453","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695453?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:36","pubTimestamp":1789418160,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 1.87% to $146.41 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.48% to 7,619.98 and Dow Jones Industrial Average  falling 0.29% to 52,421.20.The stock's rise snapped a five-day losing streak.Gilead Sciences Inc. closed 6.92% below its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  rose 0.28% to $266.32, Pfizer Inc.  remained unchanged, and Abbott Laboratories  rose 1.12% to $103.09.Trading volume  remained 1.5 million below its 50-day average volume of 6.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","LU2468319806.SGD","IE00BSNM7G36.USD","LU0109394709.USD","LU2087621335.USD","IE00BKVL7J92.USD","LU1037948897.HKD","TMED","BK4550","LU1674673691.USD","LU1839511570.USD","LU0965509101.SGD","LU1430594728.SGD","LU0882574055.USD","TBXU","IE00BZ1G4Q59.USD","BK4532","LU1057294990.SGD","LU0965509010.AUD","BMED","LU0965509283.SGD","GILD","LU1674673428.USD","MEDI","LU1571399168.USD","IE00B19Z3B42.SGD","SG9999015945.SGD","LU1023059063.AUD","LU0058720904.USD","IE00B3T34201.USD","IBB","LU1778281490.HKD","LU1934455863.HKD","LU0823416689.USD","LU2112291526.USD","SG9999015978.USD","BK4568","LU0114720955.EUR","LU1934455194.USD","IBBQ","LU2324357040.USD","BK4566","IE00B19Z3581.USD","LU1066051498.USD","LU2089984988.USD","LU1934455277.USD","SG9999015986.USD","LU1037948541.HKD","LU0861579265.USD","LU0234570918.USD","BBH","LU0965508806.USD","LU1066053197.SGD","LU1585245621.USD","LU2357627491.SGD","SG9999015952.SGD","LU0320765992.SGD","LU1061106388.HKD","BK4583","LU0859254822.USD","LU0889565916.HKD","LU0289739699.SGD","BIB","BK4139","IE0002270589.USD","IE00B7SZLL34.SGD","BK4578","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695950","title":"Amgen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695950","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695950?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:35","pubTimestamp":1789418100,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  advanced 1.10% to $381.50 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.48% to 7,619.98 and Dow Jones Industrial Average  falling 0.29% to 52,421.20.The stock's rise snapped a five-day losing streak.Amgen Inc. closed 14.66% below its 52-week high of $447.03, which the company achieved on August 25th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  rose 0.28% to $266.32, Pfizer Inc.  remained unchanged, and AbbVie Inc.  rose 1.81% to $261.77.Trading volume  eclipsed its 50-day average volume of 2.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0320765992.SGD","LU1983299246.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU2242646821.SGD","LU0868494617.USD","TBXU","LU0889565916.HKD","BK4585","LU2112291526.USD","04332","IE00BJT1NW94.SGD","BK4581","BK4566","LU1023059063.AUD","BBH","LU2468319806.SGD","PBE","LU1057294990.SGD","IE0009355771.USD","SG9999001440.SGD","LU0122379950.USD","LU2242652126.USD","LU2089984988.USD","BK4533","BK4588","BIB","BK4599","LU0058720904.USD","PJP","LU1571399168.USD","BK4139","IBB","AMGN","LU1061106388.HKD","LU0109394709.USD","LU0289739699.SGD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667070","title":"Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667070","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667070?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:30","pubTimestamp":1789403411,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. The phase 3 study A Phase 3 Randomized, Double-blind, Placebo-controlled Stu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-phase-3-dazodalibep-study-nears-data-spotlight-for-sjogrens-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-phase-3-dazodalibep-study-nears-data-spotlight-for-sjogrens-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1057294990.SGD","IBBQ","IE00BJT1NW94.SGD","BK4585","PJP","LU2468319806.SGD","BK4581","LU0122379950.USD","BK4588","IBB","BK4211","LU2242646821.SGD","BBH","AMGN","LU2089984988.USD","TBXU","ISBC","BK4599","BK4566","LU0058720904.USD","LU0109394709.USD","LU2112291526.USD","SG9999001440.SGD","BK4139","LU1023059063.AUD","BK4534","LU2242652126.USD","IE0009355771.USD","LU0868494617.USD","BIB","BK4533","LU1983299246.USD","LU0289739699.SGD","LU1061106388.HKD","LU1571399168.USD","PBE","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661729","title":"Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661729","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661729?lang=en_us&edition=fundamental","pubTime":"2026-09-14 22:04","pubTimestamp":1789394640,"startTime":"0","endTime":"0","summary":"1404 GMT - Roche Holding and GSK's Chinese partners reported strong clinical-trial data for their respective lung-cancer drug candidates in China-only clinical trials, analysts at J.P. Morgan write in a research note. Both drugs, one from GSK and partner Hansoh Pharmaceutical and another from Roche and MediLink, showed a 54% improvement in overall survival rates in the trials. This seems competitive relative to a 40% benefit shown by Amgen's Imdelltra in a global trial, the analysts say. Roche and MediLink's candidate tam-peli has a better tolerability profile than GSK and Hansoh's ris-rez, they add. Ris-rez has better median overall-survival data, but it will be important to confirm this result in a global trial, according to JPM. GSK shares rise 4.6% and Roche's jump 5.7%, while Hansoh's close 5.1% higher.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","BK4566","PBE","IBBQ","03165","LU1829250122.USD","IE00BJT1NW94.SGD","LU2089984988.USD","IE0009355771.USD","PJP","BK4532","BK4533","BK4599","RHHBY","LU1057294990.SGD","IE0002141913.USD","SG9999001440.SGD","LU2468319806.SGD","BIB","BK1191","LU0109394709.USD","GSKH","LU0058720904.USD","TBXU","BK4581","LU0868494617.USD","LU2242652126.USD","LU1061106388.HKD","BK4534","LU0889565916.HKD","BK1589","GSK","LU1571399168.USD","LU2112291526.USD","AMGN","IE00BJJMRZ35.SGD","LU1983299246.USD","BBH","HRTS","LU0320765992.SGD","LU1023059063.AUD","LU0289739699.SGD","BK4007","IBB","BK4585","CANC","IE00B2B36J28.USD","IE00B4R5TH58.HKD","GSK.UK","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661630","title":"Biofrontera announces FDA approval of Ameluz supplemental new drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661630","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661630?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:35","pubTimestamp":1789392922,"startTime":"0","endTime":"0","summary":"Biofrontera (BFRI) announced that the FDA has approved the company’s supplemental new drug application, or sNDA, for Ameluz topical gel, 10%, in co...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","IDNA","BMED","LFSC","BFRI","FRTY","MRNY","TBXU","GDOC","TECB","SYNB","LABU","BBP","GNMX","PINK","IYH","PSCH","NVIB","BK4007","IBB","BK4585","MRNX","RSPH","XLVX","BK4588","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667669562","title":"FDA Approves Shorter Monitoring Time for Amgen’s Imdelltra First Two Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=2667669562","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667669562?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:06","pubTimestamp":1789391173,"startTime":"0","endTime":"0","summary":"FDA approves shorter monitoring time for Amgen’s Imdelltra first two dosesFDA cleared a label update for Amgen’s IMDELLTRA that cuts post-infusion monitoring for the first two doses to 6-8 hours.Prior","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDLtJX3g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","TBXU","BBH","PJP","LU0320765992.SGD","BIB","BK4139","IE0009355771.USD","BK4588","IBB","LU0058720904.USD","LU2112291526.USD","LU2089984988.USD","PBE","IE00BFTCPJ56.SGD","BK4585","LU0289739699.SGD","LU0889565916.HKD","BK4534","BK4599","BK4533","LU2468319806.SGD","IE00B4R5TH58.HKD","LU1571399168.USD","BK4566","IE00BJJMRZ35.SGD","SG9999001440.SGD","AMGN","LU0109394709.USD","LU1983299246.USD","IBBQ","IE0002141913.USD","LU0122379950.USD","LU1023059063.AUD","LU2242646821.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4581","LU2242652126.USD","LU1061106388.HKD","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667778666","title":"Amgen - Imdelltra Monitoring Reduced to 6-8 Hours for First Two Infusions","url":"https://stock-news.laohu8.com/highlight/detail?id=2667778666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667778666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:00","pubTimestamp":1789390805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA41PDLW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1057294990.SGD","IE00B2B36J28.USD","BK4533","TBXU","BK4588","LU1061106388.HKD","BIB","LU0889565916.HKD","LU1571399168.USD","LU0289739699.SGD","IE0002141913.USD","IBB","PJP","BK4534","SG9999001440.SGD","BK4566","LU0122379950.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","IBBQ","IE0009355771.USD","LU1983299246.USD","LU0058720904.USD","LU0109394709.USD","BK4581","LU0320765992.SGD","LU2242652126.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU1023059063.AUD","BK4599","LU0868494617.USD","LU2089984988.USD","PBE","AMGN","BK4139","LU2112291526.USD","IE00BJT1NW94.SGD","BBH","BK4585","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667774666","title":"Amgen - Imdelltra Monitoring Remains 6-8 Hours for Third Dose, 3-4 Hours for Cycles 3-4","url":"https://stock-news.laohu8.com/highlight/detail?id=2667774666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667774666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:00","pubTimestamp":1789390805,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA41PDLW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","BK4534","LU0289739699.SGD","LU0889565916.HKD","LU0320765992.SGD","LU1983299246.USD","LU2242652126.USD","AMGN","IBBQ","IE00B4R5TH58.HKD","PJP","LU0122379950.USD","LU2468319806.SGD","LU1023059063.AUD","BK4533","IE00B2B36J28.USD","BK4599","LU2242646821.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","SG9999001440.SGD","TBXU","LU1061106388.HKD","PBE","IE00BJT1NW94.SGD","BIB","LU2112291526.USD","LU2089984988.USD","BK4588","BK4581","IE0002141913.USD","BK4585","IBB","LU1057294990.SGD","LU0109394709.USD","BBH","LU0868494617.USD","IE00BJJMRZ35.SGD","LU1571399168.USD","BK4139","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667701666","title":"FDA Approves Reduced Monitoring Time for First Two Doses of Imdelltra®","url":"https://stock-news.laohu8.com/highlight/detail?id=2667701666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667701666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:00","pubTimestamp":1789390805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA41PDLW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1057294990.SGD","IE00B2B36J28.USD","BK4533","TBXU","BK4588","LU1061106388.HKD","BIB","LU0889565916.HKD","LU1571399168.USD","LU0289739699.SGD","IE0002141913.USD","IBB","PJP","BK4534","SG9999001440.SGD","BK4566","LU0122379950.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","IBBQ","IE0009355771.USD","LU1983299246.USD","LU0058720904.USD","LU0109394709.USD","BK4581","LU0320765992.SGD","LU2242652126.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU1023059063.AUD","BK4599","LU0868494617.USD","LU2089984988.USD","PBE","AMGN","BK4139","LU2112291526.USD","IE00BJT1NW94.SGD","BBH","BK4585","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667082666","title":"Amgen - Patients to Receive Follow-up Assessment After First Two Imdelltra Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=2667082666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667082666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:00","pubTimestamp":1789390805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA41PDLW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","LU0889565916.HKD","LU2112291526.USD","IE0002141913.USD","LU1023059063.AUD","BK4139","BBH","IE00BJT1NW94.SGD","PJP","LU0058720904.USD","LU1057294990.SGD","BK4588","BK4581","BK4534","LU2089984988.USD","AMGN","IE00BFTCPJ56.SGD","LU1983299246.USD","BK4585","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU1061106388.HKD","BK4566","BIB","LU1571399168.USD","PBE","LU0320765992.SGD","BK4533","LU0109394709.USD","LU0289739699.SGD","IBBQ","BK4599","LU2468319806.SGD","TBXU","LU0122379950.USD","SG9999001440.SGD","IBB","LU2242652126.USD","LU2242646821.SGD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667066661","title":"Scholar Rock Wins FDA Approval for SMA Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2667066661","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667066661?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:32","pubTimestamp":1789389127,"startTime":"0","endTime":"0","summary":"The latest update is out from Scholar Rock Holding ( ($SRRK) ). On September 11, 2026, Scholar Rock announced U.S. FDA approval of ISEMBYLD (apiteg...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNX","PSCH","BBP","BMED","RSPH","BK4585","IBB","SYNB","BK4588","IYH","LABU","TECB","NVIB","MRNY","FRTY","IDNA","LFSC","PINK","GDOC","MEDI","XLVX","TBXU","GNMX","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667134663","title":"Scholar Rock price target raised to $84 from $76 at BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2667134663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667134663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:36","pubTimestamp":1789385772,"startTime":"0","endTime":"0","summary":"BMO Capital raised the firm’s price target on Scholar Rock (SRRK) to $84 from $76 and keeps an Outperform rating on the shares. The FDA approval of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","THNR","IBB","IYH","FRTY","MEDI","SRRK","XLVX","IBRN","IDNA","BK4588","MRNX","LFSC","NVIB","TBXU","PSCH","IEIH","RSPH","BBP","BK4139","TECB","BK4585","LABU","MRNY","BMED","GNMX","SYNB","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667659991","title":"Sino Biopharmaceutical Stock Advances 4.3% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667659991","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667659991?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:30","pubTimestamp":1789374600,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. advanced 4.3% to 5.48 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 24917.60.The stock's rise snapped a three-day losing streak.Sino Biopharmaceutical Ltd. closed 38% below its 52-week high of HK$8.86, which the company achieved Sept. 15.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 1.8% and Amgen Inc. remained unchanged.Trading volume totaled 72.9 million shares, compared to the 50-day average of 98.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","BK4534","IE00BZ08YR35.GBP","IE00BJJMRZ35.SGD","BK1515","LU1057294990.SGD","BK1191","BK4581","BK1589","01177","AMGN","IE00BFTCPJ56.SGD","LU2112291526.USD","LU0109394709.USD","LU2242646821.SGD","LU2468319806.SGD","IBB","HK0000165453.HKD","LU1571399168.USD","IE0002141913.USD","LU0122379950.USD","BK1521","BBH","LU2242652126.USD","BK4599","IE00BJT1NW94.SGD","IE00BZ08YS42.EUR","SG9999001440.SGD","LU0058720904.USD","LU0868494617.USD","PBE","LU0320765992.SGD","LU0289739699.SGD","BK4585","LU2089984988.USD","IE00B4R5TH58.HKD","TBXU","BK4139","LU1061106388.HKD","LU1983299246.USD","BK4566","IE00B2B36J28.USD","BK4588","LU0889565916.HKD","BK4533","IE0009355771.USD","LU1023059063.AUD","IBBQ","BIB","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635488","title":"Vertex Minerals Revises Timeline for Proposed Securities Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635488","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635488?lang=en_us&edition=fundamental","pubTime":"2026-09-14 07:40","pubTimestamp":1789342824,"startTime":"0","endTime":"0","summary":"Vertex Minerals Ltd. ( ($AU:VTX) ) has provided an update. Vertex Minerals Ltd. has updated its proposed securities placement timetable, revising t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-revises-timeline-for-proposed-securities-issue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-revises-timeline-for-proposed-securities-issue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BZ9MQY76.HKD","IE00BJJMRZ35.SGD","IE0009355771.USD","BK4585","LU1585245621.USD","BBH","GNMX","LU0109394709.USD","SGXZ57979304.SGD","LU2468319806.SGD","MTX","LU0757428866.USD","LU1559883803.SGD","IDNA","LU1430594728.SGD","LU1815336091.USD","BK4532","SG9999001176.USD","IBB","LU0432979614.USD","LU2462157665.USD","LU0061475181.USD","BK4533","IE00B894F039.SGD","PBE","BK4109","IE00B2B36J28.USD","LU0256863811.USD","LU1093756325.SGD","IE00BJT1NW94.SGD","BIB","LU0058720904.USD","LU0234570918.USD","LU1674673691.USD","IE00B19Z9P08.USD","LU2362541273.HKD","TBXU","LU0079474960.USD","LU2089984988.USD","VRTX","LU0320765992.SGD","LU0889565916.HKD","VERX","LU0417517546.SGD","LU1674673428.USD","IBBQ","BK4588","LU0566484027.USD","IE00B4R5TH58.HKD","SG9999001176.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635862","title":"Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635862","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635862?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:54","pubTimestamp":1789340092,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has secured U.S. FDA approval for Pixclara, the first FET-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRTY","BK4139","MRNX","GDOC","SYNB","BK4588","BK4179","PSCH","MEDI","LFSC","XLVX","FET","MRNY","IDNA","TLX","BK4585","RSPH","IYH","BBP","LABU","NVIB","GNMX","TECB","TBXU","IEIH","IBB","BMED","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666509524","title":"Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2666509524","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666509524?lang=en_us&edition=fundamental","pubTime":"2026-09-12 17:30","pubTimestamp":1789205400,"startTime":"0","endTime":"0","summary":"There is a strange paradox haunting healthcare investing right now.Heart disease remains humanity's top killer, yet for drugmakers and Wall Street, it is becoming one of the hardest places to make mon","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU0432979614.USD","LU2746668974.SGD","SGXZ51526630.SGD","LU1691799644.USD","LU2237443622.USD","LU2471134523.USD","PJP","IHE","LU1814569148.SGD","GB00BDT5M118.USD","LU0823416689.USD","LU1093756168.USD","LU0689472784.USD","ELIL","LU0354030511.USD","HRTS","BK4581","LU1064131342.USD","LU2417539215.USD","LU0154236417.USD","LU2471134879.HKD","TMED","IE00BN29S564.USD","LU2168564065.EUR","LU0323591593.USD","IE0004445239.USD","IE00BJJMRY28.SGD","LU0114720955.EUR","LU2168564149.EUR","SG9999015945.SGD","LU0158827948.USD","LU1917777945.USD","LU1023059063.AUD","LU0225283273.USD","LU2237443465.HKD","TRUH","LU1623119135.USD","BK4532","LU0882574055.USD","LU0234572021.USD","LU0787776722.HKD","LU2112291526.USD","LU0964807845.USD","IE00B7KXQ091.USD","LU2361044865.SGD","XLV","LU2468319806.SGD","LU2023250330.USD","LU0820561818.USD","LU2462591350.SGD","LU2552382132.HKD","SG9999018857.SGD","LU0203202063.USD","LU1232071149.USD","SG9999014906.USD","IE0001KFT4U8.USD","LU0708995401.HKD","ELIS","LU0289739699.SGD","LU2023250504.SGD","LU0345770308.USD","LU2236285917.USD","SGXZ31699556.SGD","LU1280957306.USD","LU1093756325.SGD","LU0058720904.USD","IBB","IE00BK4W5L77.USD","IE0002141913.USD","LU0094547139.USD","LU1720051108.HKD","LU0820562030.AUD","SGXZ81514606.USD","GDOC","LU2462157665.USD","SG9999001176.USD","LU0198837287.USD","LU0070302665.USD","LU1868837300.USD","LU0672654240.SGD","BK4533","LU0471298694.HKD","LU2471134952.CNY","PBE","LU2602419157.SGD","LU0882574139.USD","LU1145028129.USD","LU1548497426.USD","LU2471134796.USD","LU2237443549.SGD","IE00B1BXHZ80.USD","LU0079474960.USD","LU1267930730.SGD","LU1551013425.SGD","LU2242646821.SGD","LU0889565916.HKD","CANC","LU2089984988.USD","SG9999015978.USD","BK4139","LLYX","MEDI","SG9999015952.SGD","LU2242652126.USD","SG9999015986.USD","LU0122379950.USD","LU0353189763.USD","LU2237438978.USD","ILDR","BK4599","LU0471298777.SGD","LU1057294990.SGD","LU2089283258.USD","IE00BFSS8Q28.SGD","LU2028103732.USD","IE00B1XK9C88.USD","BK4585","FTXH","IE00BJJMRZ35.SGD","LU2108987350.USD","LU2111349929.HKD","LU2756315664.SGD","LU2168564495.EUR","LU1979441026.SGD","RXL","LU2361044949.HKD","IE00BJJMRX11.SGD","LU2491050071.SGD","IE00BKDWB100.SGD","LU1035775433.USD","LU2089284900.SGD","LU2456880835.USD","LU1629891620.HKD","AGNG","IE0005OL40V9.USD","IE0009355771.USD","LU2271345857.HKD","LU2324357040.USD","LU2750360641.GBP","PPH","LU2552382058.USD","LU0203201768.USD","AMGN","LU0210536198.USD","LU0238689110.USD","LU0320765992.SGD","IXJ","04332","LU1989771016.USD","LU2168563687.JPY","THNR","LU0456855351.SGD","LU1868837136.USD","NVOX","LU0385154629.USD","LU2168564222.USD","LU1069344957.HKD","IE00B775H168.HKD","LU0109391861.USD","IE00B2B36J28.USD","JDOC","LU2896262040.SGD","LU0266013472.USD","LU0345770993.USD","BK4578","MEDX","LLYZ","LU2063271972.USD","LU1712237335.SGD","IE00BZ1G4Q59.USD","OZEM","IE00BKVL7J92.USD","LU0133085943.USD","LLII","LU0683600562.USD","LU1061106388.HKD","LU0174119429.USD","LU0868494617.USD","LU2237443895.HKD","LU2213496289.HKD","IE00BK4W5M84.HKD","LU1366192091.USD","SG9999001440.SGD","LU2237443978.SGD","LU0823434740.USD","LU1804176565.USD","LU1868836591.USD","IE00BFSS7M15.SGD","SGXZ57979304.SGD","LU2106854487.HKD","LU0109394709.USD","LU0820561909.HKD","BK4588","LU1988902786.USD","NVS","LU0354030438.USD","BIB","MHIP","LU0316494557.USD","LU0320765059.SGD","LU0823434583.USD","IE00BJT1NW94.SGD","LU1291159041.SGD","LU2211815571.USD","LU0158827781.USD","LU0640476718.USD","LU0208291251.USD","LU0256863811.USD","SG9999014898.SGD","LU0943347566.SGD","CURE","LU0786609619.USD","IE00BJLML261.HKD","LU1868836914.USD","LU2357305700.SGD","NVO","WDNA","SGXZ99366536.SGD","LU2265009873.SGD","SG9999014880.SGD","LU2264538146.SGD","LU0256863902.USD","LU2552382215.SGD","SG9999018865.SGD","TBXU","LU1720051017.SGD","LU1983299246.USD","IE00B4R5TH58.HKD","IE00BKPKM429.USD","NVOH","BK4516","LU0417517546.SGD","IE0004445015.USD","LU1323610961.USD","LU1551013342.USD","LU2361045086.USD","LU2461242641.AUD","FHLC","LU2746668461.USD","LLY","LU0211331839.USD","LU0353189680.USD","LU1868836757.USD","IE00B4JS1V06.HKD","LU2491050154.USD","LU2491049909.HKD","IYH","LU2023251221.USD","LU0006306889.USD","LU0466842654.USD","LU1127390331.HKD","SG9999013999.USD","VHT","SG9999017495.SGD","LU2360106947.USD","SG9999014914.USD","LU0320765489.SGD","LU2756315318.SGD","LU2087625088.SGD","LU1974910355.USD","BK4534","IBBQ","IE00BWXC8680.SGD","BK4566","SG9999001176.SGD","LU0061475181.USD","BBH","LU1571399168.USD","LU2237443382.USD","LU2750360997.AUD","NVOC","LU0096364046.USD","IE00BFTCPJ56.SGD","LU0106261372.USD","LU0097036916.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666506002","title":"Palo Alto, Eaton, Amgen, SpaceX, LMT Trending With Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2666506002","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666506002?lang=en_us&edition=fundamental","pubTime":"2026-09-12 17:01","pubTimestamp":1789203667,"startTime":"0","endTime":"0","summary":"Analysts are intrested in these 5 stocks: ( ($PANW) ), ( ($ETN) ), ( ($AMGN) ), ( ($SPCX) ) and ( ($LMT) ). Here is a breakdown of their recent","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/palo-alto-eaton-amgen-spacex-lmt-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/palo-alto-eaton-amgen-spacex-lmt-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861558580.USD","SNK","SPCF","UFO","SSPC","WSPC","PPA","TBXU","AMGN","ELOL","IBBQ","XOVL","ORBX","DIPR","DXYZ","LOFF","DSPC","LU1244550577.SGD","LU0889565916.HKD","PJP","BIB","BK4516","SPCH","SPAL","SPCU","MISL","SPCG","XOVR","IDEF","MARS","LMT","LU1861220033.SGD","SPCQ","IBB","SPAX","PBE","WARP","SPCM","LU1162221912.USD","SHLD","NATO","BBH","FOWF","LMTL","LU1861559042.SGD","SPCX","WDGF","YSPC","LOFD","LMTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666577803","title":"Scholar Rock announces FDA approval of isembyld","url":"https://stock-news.laohu8.com/highlight/detail?id=2666577803","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666577803?lang=en_us&edition=fundamental","pubTime":"2026-09-12 06:30","pubTimestamp":1789165818,"startTime":"0","endTime":"0","summary":"Scholar Rock (SRRK) announced that the FDA has approved isembyld for the treatment of spinal muscular atrophy in adults and children two years of a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLVX","PSCH","SRRK","MRNY","IBRN","IDNA","THNR","GNMX","MRNX","NVIB","MEDI","IBB","TECB","RSPH","BK4585","BBP","BK4588","LABU","SYNB","TBXU","IYH","BMED","FRTY","BK4139","PINK","GDOC","IEIH","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666574557","title":"Amgen Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666574557","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666574557?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:35","pubTimestamp":1789158900,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  shed 1.34% to $377.35 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.86% to 7,656.98 and the Dow Jones Industrial Average  rising 0.98% to 52,573.29.This was the stock's fifth consecutive day of losses.Amgen Inc. closed 15.59% below its 52-week high of $447.03, which the company achieved on August 25th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  fell 0.29% to $265.58, Pfizer Inc.  rose 0.25% to $27.72, and AbbVie Inc.  rose 0.83% to $257.12.Trading volume  remained 337,805 below its 50-day average volume of 2.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 11, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","TBXU","IE00BFTCPJ56.SGD","LU1983299246.USD","BK4588","IE00B2B36J28.USD","LU1571399168.USD","BK4139","AMGN","LU2468319806.SGD","LU0868494617.USD","BK4566","LU1061106388.HKD","LU0058720904.USD","IBB","BK4585","LU0320765992.SGD","BIB","IE0009355771.USD","04332","LU2112291526.USD","LU1057294990.SGD","IBBQ","IE0002141913.USD","PJP","BK4533","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","BK4599","LU2089984988.USD","LU0122379950.USD","LU2242652126.USD","PBE","SG9999001440.SGD","LU0109394709.USD","LU2242646821.SGD","LU0289739699.SGD","IE00BJT1NW94.SGD","LU1023059063.AUD","BK4534","BBH","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}